Latest Breaking News On - Huadong medicine investment holding co ltd - Page 1 : comparemela.com

Ashvattha Therapeutics Announces $69 Million in Series B Financing and up to $45M Exclusive License Agreement with Huadong to Advance Hydroxyl Dendrimer-Based Precision Medicines - read this article along with other careers information, tips and advice on BioSpace

Jeffrey clelandKannan rangaramanujamJordyn temperatoLifesci communicationsHuadong medicine investment holding co ltdNatural capital investment fundSujatha kannan at johns hopkins universitySeriesb financingPlum alley investmentsTribe capitalNatural capitalPlum alleyHuadong medicineSujatha kannanJohns hopkinsShvattha therapeutics announces 69 million in seriesb financing and up to 45m exclusive license agreement with huadong advance hydroxyl dendrimer based precision medicines